Overview

Role Of Phosphorus And FGF 23 In Patients With Dent Disease

Status:
Completed
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
Patients with Dent disease have suppressed levels of FGF 23 which contributes to hypercalciuria, kidney stones, nephrocalcinosis and renal failure. Supplementation with phosphorus may reduce hypercalciuria.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Mayo Clinic